Mounjaro and Acute Pancreatitis: Recognising the Signs and What to Do

Step 1: Know what pancreatitis actually feels like on Mounjaro

Most people taking Mounjaro experience some digestive upset, nausea, loose stools, an unsettled stomach in the early weeks. That discomfort is common, usually mild, and tends to ease as your body adjusts. Pancreatitis feels different, and knowing the distinction genuinely matters.

The hallmark symptom is severe pain in the upper abdomen that does not pass within an hour or two and often travels through to the back. It can arrive alongside vomiting, and the pain typically does not improve when you change position. According to the NHS medicines page for tirzepatide, patients should seek urgent medical help for any severe, persistent stomach pain while taking Mounjaro, not because every stomachache is dangerous, but because when pancreatitis does occur it needs prompt diagnosis and treatment.

It is worth understanding that the pancreas sits behind the stomach, which is why the pain radiates the way it does. If you want a fuller picture of how Mounjaro can cause pancreatitis and why the mechanism works the way it does, that page walks through the detail. Inflammation there can disrupt the digestive enzymes the organ produces, and in serious cases the condition can progress quickly. The MHRA's January 2026 Drug Safety Update (which you can review via the MHRA Drug Safety Update index) asked prescribers and patients alike to remain alert to this presentation throughout treatment, not just at the start.

Step 2: Understand your personal risk before you begin

If you are reading this because you are weighing up treatment, or because you have already started and want to feel informed, that is a reasonable place to be. For a thorough look at what the evidence says about Mounjaro and pancreatitis, including how the condition presented in clinical data, our dedicated page covers this in detail. Pancreatitis is not common on Mounjaro (the clinical trial programme involved thousands of adults) but it is not zero either, and certain factors raise an individual's baseline likelihood.

A personal history of pancreatitis is the most significant. If you have had the condition before, that needs to be discussed with a prescriber before Mounjaro is considered at all; some prescribers will decide the risk is not acceptable, and that judgement is theirs to make based on the whole picture. Gallstones are another factor: they are a leading cause of pancreatitis generally, and adding a GLP-1 medicine (which can influence gallbladder function) means the conversation about your gallbladder history is relevant. Heavy or regular alcohol use similarly raises risk and should be disclosed fully during your consultation.

Our clinical team goes through this individually for every patient. A quick read of how Mounjaro's broader side-effect profile is managed may also help you frame the right questions before you start, and our clinical team page explains the prescriber oversight that sits behind every treatment decision at nume.

Step 3: Act quickly, when to get medical help

This is the practical core of the page, and it is straightforward: if you develop sudden, severe upper abdominal pain that does not ease within a short time, especially if it reaches into your back, stop waiting and get help. Call 111 if you are uncertain, or go to A&E if the pain is severe. Tell the clinician you are taking Mounjaro (tirzepatide) and the dose you are on.

Do not try to manage this at home with over-the-counter painkillers while waiting to see whether it settles. If you are unsure whether your symptoms point to this condition, our page addressing whether Mounjaro can cause pancreatitis and what that risk really means in practice may help you think it through before speaking to a clinician. Acute pancreatitis is diagnosed through blood tests (amylase and lipase levels) and sometimes imaging; you cannot assess it yourself. Treatment typically involves hospital admission, fluids and monitoring.

If you have had an episode and recovered, the question of whether to restart Mounjaro is one for your prescriber to lead on, there is no single answer, and it depends on the cause and severity. The NHS guidance on weight-management injections sets out the general framework for clinical decision-making in this area. For questions specifically about how pancreatitis risk compares across situations and doses, our pages covering the risk of pancreatitis with Mounjaro and steps that may reduce that risk go into more depth.

Step 4: Keep your prescriber and your GP informed

Acute pancreatitis does not come with advance warning, which is why the before-you-start conversation matters as much as knowing what to do if it happens. At nume (at nume) our prescribers notify your GP as part of treatment initiation, in line with GPhC guidance. That means your GP has a record of your medication and can act quickly if you present with symptoms.

If anything changes during treatment (a new episode of abdominal pain, a change in your gallbladder history, a new diagnosis) contact your prescriber through aftercare, available seven days a week. You can also report any suspected side effect directly to the MHRA via the Yellow Card scheme; patient reports genuinely contribute to the safety monitoring that updates guidance like the January 2026 communication. Raising concerns is never a sign you did something wrong, it is part of how safe prescribing works.

If you are still weighing up whether Mounjaro is right for you, or you want a prescriber to review your specific risk factors, our free consultation is the place to start. There is no obligation, and side-effect questions are a routine and welcome part of those conversations.